Newsroom

Sorted by: Latest

-

Deadline Approaching: Phreesia Inc. (PHR) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming July 13, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Phreesia Inc. (“Phreesia” or the “Company”) (NYSE: PHR) common stock between May 8, 2025 and March 30, 2026, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PHREESIA INC. (PHR), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE ONGOING SECURITIES...
-

BeOne Medicines gibt bekannt, dass die Phase-3-Daten der Studie HERIZON-GEA im NEJM veröffentlicht und auf der ASCO 2026 vorgestellt wurden

SAN CARLOS, Kalifornien--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), ein weltweit tätiges Onkologieunternehmen, gab heute bekannt, dass Daten aus der Studie HERIZON-GEA-01 im The New England Journal of Medicine veröffentlicht wurden und im Rahmen einer mündlichen Präsentation (Rapid Oral Abstract: 4010) auf der Jahrestagung der American Society of Clinical Oncology (ASCO) am 1. Juni 2026 in Chicago vorgestellt werden. In der klinischen Studie HERIZON-GEA-01 wu...
-

BeOne Medicines annonce les données de l'essai HERIZON-GEA de phase 3 publiées dans le NEJM et présentées à l'ASCO 2026

SAN CARLOS, Californie--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq : ONC ; HKEX : 06160 ; SSE : 688235), une société mondiale d'oncologie, annonce aujourd'hui que les données de HERIZON-GEA-01 ont été publiées dans The New England Journal of Medicine et seront partagées dans le cadre d'une présentation orale (Rapid Oral Abstract : 4010) à la réunion annuelle de l'American Society of Clinical Oncology (ASCO) le 1er juin 2026, à Chicago. L'essai clinique HERIZON-GEA-01 a évalué le ZIIHERA® (za...
-

Xtrackers (IE) plc UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Xtrackers (IE) plc Investment Company with Variable Capital Registered Office: 78 Sir John Rogerson's Quay, Dublin 2, Ireland Registration number: 393802 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Dublin, 27 May 2026 This announcement is to inform the shareholders of the sub-funds listed in the table below (each a Sub-Fund, and together the Sub-Funds) (the Shareholders) on behalf of the board of directors of the Company...
-

Verallia: Result of the Option to Receive the 2025 Dividend Payment in New Shares

PARIS--(BUSINESS WIRE)--Regulatory News: The Shareholders’ General Meeting of the Company held on April 24th 2026 approved the payment of a dividend of 1 euro per share and decided to propose to each shareholder, in respect of the payment of the dividend for the financial year ended December 31, 2025, an option between the payment of the dividend in cash or in newly issued shares of the Company, each of these options being mutually exclusive. The issue price of each share to be delivered for pa...
-

Verallia: Résultat de l’option pour le paiement du dividende 2025 en actions

PARIS--(BUSINESS WIRE)--Regulatory News : L’Assemblée Générale des actionnaires de la Société réunie le 24 avril 2026 a approuvé le versement d’un dividende d’1 euro par action et décidé de proposer à chaque actionnaire, au titre du paiement du dividende de l’exercice clos le 31 décembre 2025, une option entre le paiement du dividende en numéraire ou en actions nouvelles de la Société, chacun de ces choix étant exclusif de l’autre. Le prix d’émission de chaque action nouvelle remise en paiement...
-

Ansay & Associates Supports Local Communities Through Volunteer Time, Charitable Giving and Development Efforts

PORT WASHINGTON, Wis.--(BUSINESS WIRE)--Ansay & Associates strengthens community impact across its 34 locations through employee volunteer time, charitable giving and community development....
-

Law Offices of Howard G. Smith Encourages Calix, Inc. (CALX) Shareholders To Inquire About Securities Fraud Class Action

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Calix, Inc. (“Calix” or the “Company”) (NYSE: CALX) securities between January 28, 2026 and April 21, 2026, inclusive (the “Class Period”). Calix investors have until July 27, 2026 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CALIX, INC. (CALX), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE O...
-

Kontron Launches VX30101 High End 3U VPX Board

TOULON, France--(BUSINESS WIRE)--Kontron, a leading global provider of IoT/embedded computer technology (ECT), today announces the upcoming Kontron VX30101. This new-generation 3U VPX High-End Computing Board is designed for AI-enabled mission computing, sensor fusion, rugged embedded servers and tactical edge applications. The ruggedized SWaP-C optimized VX30101 delivers high-performance heterogeneous computing, integrated AI acceleration and ultra-fast networking capabilities. It is among the...
-

AeroVironment, Inc. (AVAV) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of AeroVironment, Inc. (“AeroVironment” or the “Company”) (NASDAQ: AVAV) investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN AEROVIRONMENT, INC. (AVAV), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal right...